Johnson & Johnson (JNJ): FY25 Q2 earnings call, Jul 16, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Jul 16, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
6 matches for “Ottava”; 4 quoted, at least 25 words apart.
…advanced stapling technology will be harnessed for future use exclusively on the OTTAVA robotic surgery system. And as mentioned on our earnings call in April,…
…medtech, we continue to make progress with our clinical trials for our OTTAVA robotic surgical system. In our cardiovascular portfolio, we are planning regulatory submission…
…And so feel very confident about the progress that we're making on OTTAVA. I think you know clearly why we feel that we have strong…
…leadership position, both in open and lap surgery with the launch of OTTAVA, which you know is on the horizon. I'd say the 2 biggest…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-07-16:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP